ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 25-07-2018
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.0% As on (31-10-2023)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 3,270.55 Cr As on (31-10-2023)
Turn over: 62
NAV as on 24-11-2023

25.5

0.11 (0.4314%)

CAGR Since Inception

19.3%

S&P BSE Healthcare TRI 13.93%

PERFORMANCE of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Scheme Performance (%) Data as on - 28-11-2023

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 30.7 15.95 20.49 - 19.3
S&P BSE Healthcare TRI 25.91 14.18 17.03 12.85 13.93
Equity: Sectoral-Pharma and Healthcare 24.97 14.2 19.87 15.03 15.34

Yearly Performance (%)

Nav Movement

Fund Managers

Dharmesh Kakkad, Sharmila D'mello

Investment Objective

The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

RETURNS CALCULATOR for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 14.2 0.71 2.09 0.89 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Period
Data as on - 28-11-2023
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 30.7 13.2 15.95 20.49 0.0
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 29.01 10.24 16.09 19.95 16.93
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 27.9 8.93 13.45 18.53 13.3
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 27.34 13.11 16.12 19.43 14.86
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 25.66 7.6 12.94 0.0 0.0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 25.55 10.41 14.79 19.6 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 24.34 11.49 15.18 0.0 0.0
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 22.28 7.05 14.85 21.21 0.0
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 20.19 7.62 0.0 0.0 0.0
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 16.77 3.39 8.47 0.0 0.0

PORTFOLIO ANALYSIS of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Asset Allocation (%)